Clinical Trial Summary Phase 1 & II, Interventional, multi-center, randomized, single-arm, multiple ascending dose study to evaluate the safety, pharmacokinetics & pharmacodynamics in patients diagnosed with AML The purpose of this study is to determine the safety, tolerability, dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of CXD in patients... Read more